|
Up a level |
Ture, M; Jenewein, J; Angst, F; Aeschlimann, A; Martin-Soelch, C; Schnyder, U; Walt, H (2015). Onkologische Rehabilitation in der Schweiz: Aktuelle Situation und Zukunft. Schweizer Krebsbulletin, (1):21-22.
Ture, M; Barth, J; Angst, F; Aeschlimann, A; Schnyder, U; Zerkiebel, N; Perseus, J; Renner, C; Imesch, P; Fuchs, B; Huber, G F; Walt, H; Martin-Soelch, C; Jenewein, J (2015). Use of inpatient rehabilitation for cancer patients in Switzerland: Who undergoes cancer rehabilitation? Swiss Medical Weekly, 145:w14214.
Ture, M; Jenewein, J; Angst, F; Aeschlimann, A; Martin-Soelch, C; Schnyder, U; Walt, H (2013). Outcome and effectiveness of cancer rehabilitation in Switzerland: A study protocol. Schweizer Krebsbulletin, 33(2):123 -124.
Besic Gyenge, E; Hiestand, S; Graefe, S; Walt, H; Maake, C (2011). Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in-vitro. Photodiagnosis and Photodynamic Therapy, 8(2):86-96.
Besic Gyenge, E; Darphin, X; Walt, H; Maake, C (2011). Uptake and distribution of silica-shell nano particles in head-and-neck cancer cell lines. Journal of Nanobiotechnology, 9:32-45.
Lüthi, M; Besic Gyenge, E; Engström, M; Bredell, M; Grätz, K W; Walt, H; Gmür, R; Maake, C (2009). Hypericin- and mTHPC-mediated photodynamic therapy for the treatment of cariogenic bacteria. Medical Laser Application, 24(4):227-236.